These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 151910)

  • 21. Dissociation of lymphocyte activating determinants from recognition sites in mouse MLR.
    Abbasi K; Festenstein H; Verbi W; Roitt IM
    Nature; 1974 Sep; 251(5472):227-9. PubMed ID: 4138667
    [No Abstract]   [Full Text] [Related]  

  • 22. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capacity of C3H X CBA spleen cells to depress the MLC response of CBA mice specifically. Evidence for an active role of the injected cells.
    Jacobsson H; Lilliehöök B; Blomgren H
    Cell Immunol; 1976 Mar; 22(1):53-65. PubMed ID: 132274
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on non-H-2 linked lymphocyte activating determinants. I. Description of the cell type bearing the Mls product.
    Ahmed A; Scher I; Smith AH; Sell KW
    J Immunogenet; 1977 Jun; 4(3):201-13. PubMed ID: 70491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct alloantigens trigger proliferative or nonproliferative T lymphocyte activation in CBA/N, CBA/J, and C3H mice.
    Giovarelli M; Landolfo S; Scher I; Forni G
    Transplantation; 1982 Mar; 33(3):260-4. PubMed ID: 7039035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Mlsd-defined primary mixed lymphocyte reaction: a composite response to Mlsa and Mlsc determinants.
    Ryan JJ; Mond JJ; Finkelman FD
    J Immunol; 1987 Jun; 138(12):4085-92. PubMed ID: 2438333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional antigen binding by the defective B cells of CBA/N mice.
    Snippe H; Merchant B; Lizzio EF; Inman JK
    Adv Exp Med Biol; 1982; 149():91-6. PubMed ID: 6983243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemopoietic reconstitution obtained in F1 hybrids by grafting of parental marrow cells.
    von Boehmer H; Sprent J; Nabholz M
    Transplant Proc; 1976 Sep; 8(3):355-8. PubMed ID: 136073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Phenomenon of parental resistance and its genetic regulation].
    Fontalin LN; Kondrat'eva TK; Novikova TK; Blandova ZK
    Biull Eksp Biol Med; 1979 Mar; 87(3):247-50. PubMed ID: 34452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recent antigen priming on adoptive immune responses. III. Antigen-induced selective recruitment of subsets of recirculating lymphocytes reactive to H-2 determinants.
    Sprent J; Miller JF
    J Exp Med; 1976 Mar; 143(3):585-600. PubMed ID: 55460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of the maternal effect on allogenic inhibition of hematopoietic stem cells].
    Golovistikov IN; Gambarov SS
    Genetika; 1976; 12(6):70-4. PubMed ID: 11151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. III. Study of the mechanism.
    Cibotti R; Churaqui E; Bolonakis-Tsilivakos I; Scott-Algara D; Hallepannenko O; Kosmatopoulos K
    J Immunol; 1989 Dec; 143(11):3484-91. PubMed ID: 2573634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    Gautam SC; Hilfiker ML; Battisto JR
    J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on non-H-2-linked lymphocyte-activating determinants. IV. Ontogeny of the Mls product on murine B cells.
    Ahmed A; Scher I; Sell KW
    Cell Immunol; 1977 Apr; 30(1):122-34. PubMed ID: 67901
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of helper T cells for B lymphocytes in primary mixed lymphocyte cultures.
    Pobor G; Pettersson S; Bandeira A; Martinez C; Coutinho A
    Scand J Immunol; 1983 Sep; 18(3):207-15. PubMed ID: 6194556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of tolerance against the MLs antigen in mice: no need for MLs-bearing cells.
    Lilliehöök B; Blomgren H; Jacobsson H; Andersson B
    Cell Immunol; 1977 Mar; 29(2):223-31. PubMed ID: 140765
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice.
    Cohen PL; Scher I; Mosier DE
    J Immunol; 1976 Feb; 116(2):301-4. PubMed ID: 55435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.